Covalent coating of hydroxyapatite by keratin stabilizes gentamicin release

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 89, Issue 1, 2009, Pages 102-113

  Belcarz, Anna ^a   Glnalska, Grazyna ^a   Zalewska, Justyna ^a   RzeskI, Wojciech ^b   Ślósarczyk, Anna ^c   Kowalczuk, Dorota ^a   Godlewski, Piotr ^a   Niedzwiadek, Justyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

Author keywords

Antibacterial; Controlled drug release; Hydroxyapatite; Keratin; Osteoblasts; Porosity

Indexed keywords

ANTI-BACTERIAL ACTIVITIES; ANTIBACTERIAL; BACTERIAL GROWTHS; CONTROLLED DRUG RELEASE; HUMAN OSTEOBLASTS; KERATIN; MATRIXES; OSTEOBLAST PROLIFERATIONS;

APATITE; GRANULATION; HAZARDOUS MATERIALS; HYDROXYAPATITE;

OSTEOBLASTS;

3 AMINOPROPYLTRIETHOXYSILANE; BIOMATERIAL; DRUG CARRIER; GELATIN; GENTAMICIN; HYDROXYAPATITE; KERATIN; LACTATE DEHYDROGENASE; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CELL LINE; CELL PROLIFERATION; CHEMICAL MODIFICATION; COATED PARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; COVALENT BOND; CYTOTOXICITY; DRUG IMMOBILIZATION METHOD; DRUG RELEASE; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; OSTEOBLAST; PROTEIN IMMOBILIZATION; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; TECHNIQUE; AMINO ACID SEQUENCE; CHEMISTRY; DRUG DELIVERY SYSTEM; EVALUATION; MATERIALS TESTING; METABOLISM; MOLECULAR GENETICS; SEQUENCE ALIGNMENT; SURFACE PROPERTY;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; CELL LINE; COATED MATERIALS, BIOCOMPATIBLE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DURAPATITE; GENTAMICINS; HUMANS; KERATINS; MATERIALS TESTING; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; SURFACE PROPERTIES;

EID: 65549127212     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31192     Document Type: Article

References (56)

1. Sopyan YI, Mel M, Ramesh S, Khalid KA, Porous hydroxy-apatite for artificial bone applications, Sci Tech Adv Mater 2007;8:1 16-123.
2. Wen J, Leng Y, Chen J, Zhang C, Chemical gradient in plasma-sprayed HA coatings. Biomaterials 2000;21:1339-1343.
3. Verret DJ, Dudic Y, Oxford L, Smith J, Hydroxyapatite cement in craniofacial reconstruction. Otolaryngol Head Neck Surg 2005; 133:897-899.
4. Clark WB, Lane MD, Beem JE, Bragg SL, Wheeler TT. Relative hydrofobicities of Actinomyces viscosus and Actinomyces naeslundii strains and their adsorption to saliva-treated hydroxyapatite. Infect Immun 1985;47:730-736.
5. Aronov D, Karlov A, Rosenman G. Hydroxyapatite nanocer-amics: Basic physical properties and biointerface modification. J Eur Ceram Soc 2007;27:4181-4196.
6. Arciola CR, Montanaro L, Moroni A, Giordano M, Pizzofer-rato A, Donati ME, Hydroxyapatite-coated orthopaedic screws as infection resistant materials: In vivo study. Biomaterials 1999;20:323-327.
7. You J-R, Seo J-H, Kim Y-H, Choi W-C. Six cases of bacterial infection in porous orbital implants. Jpn J Ophthalmol 2003;47:512-518.
8. Jordan DR. Chan S, Mawn L, Gilberg S, Dean T, Brownstein S, Hill VE. Complications associated with pegging hydroxyapatite orbital implants. Opthalmology 1999; 106:505-512.
9. Stitger M, de Groot K, Laroyle P. Incorporation of tobramy-cin into biomimetoc hydroxyapatite coating on titanium. Biomaterials 2002;23:4143-4153.
10. Gerritsma-Bleeker CLE, Deutman R, Mulder Th J, Steinberg JDJ. The Stanmore total hip replacement. A 22-year follow-up. J Bone Joint Surg Br 2000;82;97-102.
11. Shinto Y, Uchida A, Korkusuz F, Araki N, Ono K. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J Bone Joint Surg 1992;74:600-604.
12. Yamashita Y, Uchida A, Yamakawa T, Shinto Y, Araki N, Kato K. Treatment of chromic osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotics. Int Orthopedics 1998;22:247-251.
13. Ślósarczyk A, Szymura-Oleksiak J, Mycek B. The kinetics of pentoxyfilline release from drug-loaded hydroxyapatite implants. Biomaterials 2000;21:1215-1221.
14. Stitger M, Bezemer J, de Groot K, Layrolle P. Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy. J Control Release 2004;99:127-137.
15. Buranapanitkit B, Srinilta V, Ingviga N, Oungbho K, Geater A, Ovatlarnporn C. The efficacy of a hydroxyapatite composite as a biodegradable antibiotic delivery system. Clin Orthop Reiat Res 2004;424:244-252.
16. Baro M, Sánchez E, Delgado A, Perera A, Évora C. In vitro-in vivo characterization of gentamicin bone implants. J Control Release 2002;83:353-364.
17. Sánchez E, Baro M, Soriano I, Perera A, Évora C. In vivo-in vitro study of biodegradable and osteointegrable gentamicin bone implants. Eur J Pharm Biopharm 2001;52:151-158.
18. Sivakumar M, Panduranga Rao K. Preparation, characterization and in vitro release of gentamicin from coralline hydroxyapatite-gelatin composite microspheres. Biomaterials 2002;23:3175-3181.
19. Tanaka T, Hirose M, Kotobuki N, Ohgushi H, Furuzono T, Sato J. Nano-scaled hydroxyapatite/silk fibroin sheets support osteogenic differentiation of rat bone marrow mesenchymal cells. Mater Sci Eng 2007;27:817-823.
20. Tachibana A, Kaneko S, Tanabe T, Yamauchi K. Rapid fabrication of keratin-hydroxyapatite sponges toward osteoblast cultivation and differentiation. Biomaterials 2005;26;297-302.
21. Tachibana A, Furuta Y, Takeshima H, Tanabe T, Yamauchi K. Fabrication of wool keratin sponge scaffolds for long-term cell cultivation. J Biotechnol 2002;93:165-170.
22. Ginalska G, Osińska M, Uryniak A. A covalent method of gentamicin bonding to silica supports. J Biomater Appl 2004; 18:279-291.
23. Ginalska G, Kowalczuk D, Osińska M. A chemical method of gentamicin bonding to gelatine-sealed prosthetic vascular grafts. Int J Pharm 2005;288:131-140.
24. Ginalska G, Osińska M, Uryniak A, Urbanik-Sypniewska T, Belcarz A, Rzeski W, Wolski A. Antibacterial activity of gen-tamicin-bonded gelatin-sealed polyethylene terephthalate vascular prostheses. Eur J Vasc Endovasc Surg 2005;29:419-424.
25. Ginalska G, Kowalczuk D, Osińska M. Amikacin-loaded vascular prosthesis as an effective drug carrier. Int J Pharm 2007;339:39-46.
26. Weethall H. Covalent coupling methods for inorganic support material. Methods Enzymol 1976;44:134-148.
27. Schacterle GR, Pollack RL. A simplified method for the quantitative assay of small amounts of protein in biologic material. Anal Biochem 1973;51:654-655.
28. Ginalska G, Uryniak A, Łobarzewski J, Osińska M. A method of antibiotic immobilization. Polish Patent Pending P-358934, 2004:128:18:801.
29. British Pharmacopoeia I. London: HMSO; 1999. pp 695-697.
30. Cabanillas PF, Dièz-Peña E, Barrales-Rienda IM, Frutos G. Validation of in vitro characterization of antibiotic-loaded bone cement release. Int J Pharm 2000;209:15-26.
31. Rozalska B, Sadowska B, Wieckowska M, Rudnicka W. Detection of bacterial biofilm on medical biomaterials. Med Dosw Mikrobiol 1998;50:1 15-122.
32. Chang MC, Ko C-C, Douglas WH. Preparation of hydroxyap-atite-gelatin nanocomposite. Biomaterials 2003;24:2853-2862.
33. Ramnani P, Singh R, Gupta R. Keratinolytic potential of Bacillus licheniformis RG1: Structural and biochemical mechanism of feather degradation. Can J Microbiol 2005;51:191-196.
34. Ichida JM, Krizova L, LeFevre CA, Keener HM, Elwell DL, Burnt EH Jr. Bacterial inoculum enhances keratin degradation and biofilm formation in poultry compost. J Microbiol Methods 2001;47:199-208.
35. Riffel A, Lucas F, Heeb P, Brandelli A. Characterization of a new keratinolytic bacterium that completely degrades native feather keratin. Arch Microbiol 2003; 179:258-265.
36. Yamauchi K, Hojo H, Yamamoto Y, Tanabe T. Enhanced cell adhesion on RGDS-carrying keratin film. Mater Sci Eng 2003;23:467-472.
37. Joosten U, Joist A, Gosgeher G, Liljenqvist U, Brandt B, von Eiff C. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. Biomaterials 2005;26:5251-5258.
38. Dion A, Langman M, Hall G, Filiaggi M. Vancomycin release behaviour from amorphous calcium polyphosphate matrices intended for osteomyelitis treatment. Biomaterials 2005;26: 276-285.
39. Itokazu M, Yang W, Aoki T, Ohara A, Kato N. Synthesis of antibiotic-loaded interporous hydroxyapatite blocks by vacuum method and in vitro drug release testing. Biomaterials 1998;19:817-819.
40. Belcarz A, Zalewska J, Ginalska G, Ślósarczyk A. Gentamicin immobilization on hydroxyapatite carriers for increasing their antibacterial properties. Eng Biomater 2005;47:34-36.
41. Woodard JR, Hiildore AJ, La SK, Park CJ, Morgan AW, Eur-ell JAC, Clark SG, Wheeler MB, Jamison RD, Johnson AJW. The mechanical properties and osteoconductivity of hydroxa-patite bone scaffolds with multiscale porosity. Biomaterials 2007;28:45-54.
42. Hing KA, Annaz B, Saeed S, Revell PA, Buckland T. Micro-porosity enhances bioactivity of synthetic bone graft substitutes. J Mater Sci Mater Med 2005;16:467-475.
43. Bignon A, Chouteau J, Chevalier J, Fantozzi G, Garret J-P, Chevassieux P, Boivin G, Melin M, Hartmann D. Effect of micro- and macroporosity of bone substitutes on their mechanical properties and cellular response. J Mater Sci Mater Med 2003;14:1089-1097.
44. Habibovic P, Yuan H, van der Valk CM, Meijer G, van Blit-terswijk CA, de Groot K. 3D microenvironment as essential element for osteoinduction by biomaterials. Biomaterials 2005; 26:3565-3575.
45. Joosten U, Joist A, Frebel T, Brandt B, Diederichs S, von Eiff C. Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis. Biomaterials 2004;25:4287-4295.
46. Senyk GF, Kozlowski SM, Noar PS, Shipe WF, Bandler DK. Comparison of dry culture medium and conventional plating techniques for enumeration of bacteria in pasteurized fluid milk. J Dairy Sci 1987;70:1152-1158.
47. Gottenbos B, van der Mei HC, Busscher HJ. Initial adhesion and surface growth of Staphylococcus epidermidis and Pseudomonas aeruginosa on biomedical polymers. J Biomed Mater Res 2002;50:208-214.
48. Shor L, Güceri S, Wen X, Gandhi M, Sun W. Fabrication of three-dimensional polycaprolactone/hydroxyapatite tissue scaffolds and osteoblast-scaffold interactions in vitro. Biomaterials 2007;28:5291-5297.
49. Kino R, Ikoma T, Yunoki S, Nagai N, Tanaka J, Asakura T, Munekata M. Preparation and characterization of multilayered hydroxyapatite/silk fibroin film. J Biosci Bioeng 2007; 103: 514-520.
50. Balani K, Anderson R, Laha T, Andara M, Tercero J, Grumpier E, Agarval A. Plasma-sprayed carbon nanotube reinforced hydroxyapatite coatings and their interaction with human osteoblasts in vitro. Biomaterials 2007;28:618-624.
51. Thian ES, Huang J, Best SM, Barber ZH, Brooks RA, Rushton N, Bonfield W. The response of osteoblasts to nano-crystalline silicon-substituted hydroxyapatite thin films. Biomaterials 2006;27:2692-2698.
52. Boanini E, Torricelli P, Gazzano M, Giardino R, Bigi A. Nanocomposites of hydroxyapatite with aspartic acid and glutamic acid and their interaction with osteoblast-like cells. Biomaterials 2006;27:4428-4433.
53. Wu T-J, Huang H-H, Lan Ch-W, Lin Ch-H, Hsu F-Y, Wang Y-J. Studies on the microspheres comprised of reconstituted collagen and hydroxyapatite. Biomaterials 2004;25:651-658.
54. Cerroni L, Filocamo R, Fabbri M, Piconi C, Caropreso S, Condo SG. Growth of osteoblast-like cells on porous hydroxyapatite ceramics: An in vitro study. Biomol Eng 2002; 19:119-124.
55. Sobinsky KR, Flanigan DP. Antibiotic binding to polytetra-fluoroethylene via glucosaminoglycan-keratin luminal coating. Surgery 1986;100:629-634.
56. Chole RA, Hughes RM, Faddis BT. Keratin particle-induced osteolysis: A mouse model of inflammatory bone remodeling related to cholesteatoma. J Assoc Res Otolaryngol 2001;2:65-71.